Figure 6: Silencing PMCA2 in MDA-MB-231 breast cancer cells inhibits the percentage of cells in S-phase and reduces cell number. | Scientific Reports

Figure 6: Silencing PMCA2 in MDA-MB-231 breast cancer cells inhibits the percentage of cells in S-phase and reduces cell number.

From: The calcium pump plasma membrane Ca2+-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin

Figure 6

(A,B) Silencing PMCA2 for 120 h using ON-TARGETplus siRNA and siGenome siRNA inhibits (A) the percentage of EdU-positive cells and (B) cell number. Data are mean ± SD (n = 3) from 3 independent experiments, *P < 0.05, one-way ANOVA, Tukey’s post hoc test (left panel) or unpaired t-test (right panel).

Back to article page